17.2 Percent of Children Start but Do Not Complete Seven-Vaccine Series
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
TUESDAY, July 25, 2023 -- Overall, 17.2 percent of children initiated, but did not complete, the combined seven-vaccine early childhood series, according to a study published online July 25 in Pediatrics.
Sarah Y. Michels, M.P.H., from Yale School of Public Health in New Haven, Connecticut, and colleagues examined factors associated with starting but not completing multidose vaccine series using data from the 2019 National Immunization Survey Child. A total of 16,365 children aged 19 to 35 months were classified as completing the combined seven-vaccine series; not initiating one or more of the seven-vaccine series; or initiating all series but not completing one or more multidose series (72.9, 9.9, and 17.2 percent, respectively).
The researchers found that to complete the combined seven-vaccine series, about 8.4 percent of children needed only one additional vaccine dose from one of the five multidose series. The associations with starting but not completing multidose vaccine series were strongest for moving across state lines (adjusted prevalence ratio [aPR], 1.45), number of children in the household (aPRs, 1.29 and 1.68 for two to three and four or more, respectively), and lack of insurance coverage (aPR, 2.03).
"If children who were missing only one outstanding dose from a multidose vaccine series had received that final dose, the United States would have achieved the Healthy People 2020 goal of 80 percent coverage for combined seven-vaccine series completion in 2019," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted July 2023
Read this next
No Evidence That Live Vaccines Are Unsafe for Patients on Dupilumab
FRIDAY, June 14, 2024 -- There is no evidence to suggest that administration of live vaccines to patients receiving dupilumab is unsafe, and vaccine efficacy is not affected by...
Systemic Side Effects of COVID-19 Vaccine Tied to Greater nAB Response
TUESDAY, June 11, 2024 -- Short-term systemic side effects of the severe acute respiratory coronavirus 2 (SARS-CoV-2) mRNA vaccine are associated with greater long-lasting...
No Decline in Cardiovascular Events Seen With COVID-19 Vaccine After Acute Coronary Syndromes
MONDAY, June 3, 2024 -- Patients who have received at least one COVID-19 vaccine dose after acute coronary syndromes do not have a reduced risk for cardiovascular events...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.